Next Generation Cancer Diagnostics Market Trends and Forecast Report to 2024
The global Specialty Pulp and Paper Chemicals Market is likely to reach USD 26.23 billion by 2025, with a CAGR of 3.0% during the forecast period. Increasing importance of functional chemicals, that offer outstanding visual possessions and increase printability, is some of the numerous features motivating the development of the business.
Specialty pulp and paper chemicals are utilized by way of raw materials by the paper producing companies to manufacture the specialty paper. It supports to change and improve the useful possessions of the paper for example strength, brightness, color, and the confrontation to water. It likewise decreases the ingestion of energy and water. Similarly, specialty chemicals are utilized in the manufacturing procedure of specialty paper which decreases the generation of the paper wastage, therefore the raw material necessary for the manufacture of specialty paper is of a lesser amount as equated to standard paper.
The report “Specialty Pulp and Paper Chemicals Market” is available now at https://www.millioninsights.com/industry-reports/specialty-pulp-paper-chemicals-market
Specialty paper is utilized in a number of uses that consist of printing, packaging, labeling, writing, and others. Greater demand in the application of printing and writing in a number of nations for example the U.K., Brazil, India, China, Thailand, Germany, and the U.S.A, will trigger the demand for the product above the subsequent a small a
Global next generation cancer diagnostics market size was worth USD 4,964.05 million in 2016 which is anticipated to grow at a CAGR of more than 9.7% over the forecast period. Rise in mortality rate due to the increasing occurrence of the cancer, second most predominant disease accounting for approximately 8.8 million deaths in 2015 is anticipated to escalate the market for these tests.
Advancements in tests enable early diagnosis and assist efficient detection of different types of tumors which in turn is expected to promote growth over the projected period. The introduction of new products by large bodies, merger, and acquisitions, and joint agreements such as the development of RNA-Seq Kit version by Agilent Technologies Inc. and Agendia Inc. are the factors accountable for the estimated CAGR.
An escalation in the development of companion diagnostics in order to deliver advanced and personalized genomic medicine is also responsible for progress in the coming years.
Furthermore, the technological advancements driving the innovation in point-of-care testing devices is anticipated to aid in commercialization of advanced products thereby supporting revenue generation.
Request a Free Sample Copy of Next Generation Cancer Diagnostics Market Report @ https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics-market/request-sample
Incorporation of technological advancements such as melting curve examination for identification of mutations, qPCR tools for profiling of tumor in clinical test centers, and gene deletions are accountable for the largest share apprehended by multiplexing and qPCR segment.
With the development of next-generation sequencing technology, the use of traditional methods such as protein and DNA microarrays is expected to decrease through the years. Other factors such as data interpretation tools, growth of supportive library preparation procedures, and technological advancements are accountable for the lucrative adoption of next generation oncology tests among researchers.
Cancer Type Insights
Major categorization for the types of cancer includes cervical, breast, lung, colorectal, and other tumor forms. The other types constitute leukemia, prostate, bladder, brain, skin, uterine, esophageal, Non-Hodgkin lymphoma, ovarian, liver, and thyroid.
In 2015, as per World Health Organization lung cancer was accountable for approximately 1.7 million deaths. Moreover, breast cancer incidence is also estimated to grow thereby escalating the demand for screening and diagnostic technologies.
Growth in the number of research schemes to develop novel products and services which enable primary detection of tumor-causing mutations is expected to affect the advancement in genetic analysis over the forecast period. Biomarker tests offer greater sensitivity in screening and also demonstrate 90% accuracy levels in investigational studies which is attributive to induce progress in the coming years.
Risk analysis, prognostic based diagnosis, tumor screening, therapeutic monitoring, & theranostics are the different functions of next generation oncology diagnostic tests.
The prognostic diagnostics segment is anticipated to witness the fastest growth in the coming years as a consequence of higher adoption of prognosis which plays important role in designing oncology therapies and protocols for chemotherapy, radiation-based treatment, and gene therapy.
The report “Next Generation Cancer Diagnostics Market” is available now at Request a Free Sample Copy of Next Generation Cancer Diagnostics Market Report @ https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics-market
The next generation cancer diagnostics market is dominated by North America with approximately 40% market share. Favorable government initiatives such as launch of “80% by 2018” program for detection of colon cancer is anticipated to propel progress in the coming years.
In this program, almost 170 groups including medical professional societies, health departments, government health departments, and cancer coalitions are functioning to accomplish the mutual goal of attaining 80% screening for oncology diseases by 2018 and are working forward to eliminate the oncology disorders.
Asia Pacific is anticipated to be the fastest developing region. Factors such as economic augmentation, higher investments, and greater untapped market are accountable for the fastest growth of resign in diagnosis sector.
Major entities functioning in the market include Novartis AG, Myriad Genetics Inc., Illumina Inc., Almac Group, Sysmex Corporation, F. Hoffmann-La Roche Ltd, Agilent Technologies, Genomic Health, Almac Group, Koninklijke Philips N.V, and Cepheid.
Market players by offering clinical analysis amenities are implementing geographic expansion strategies. Furthermore, reimbursement coverage plays an important factor to increase the patient convenience to the precision drug. For example, in October 2015, U.S., Medicare started the reimbursement procedure for a prostate tumor type known as Oncotype DX.
Technology Outlook (Revenue, USD Million, 2013 – 2024)
• Next Generation Sequencing
• qPCR & Multiplexing
• Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
• Protein Microarrays
• DNA Microarrays
Application Outlook (Revenue, USD Million, 2013 – 2024)
• Biomarker Development
• CTC Analysis
• Proteomic Analysis
• Epigenetic Analysis
• Genetic Analysis
To read more reports of this category, Visit our blog: https://healthandpharamceuticalmarket.blogspot.com
Cancer Type Outlook (Revenue, USD Million, 2013 – 2024)
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
Function Outlook (Revenue, USD Million, 2013 – 2024)
• Therapeutic Monitoring
• Companion Diagnostics
• Cancer Screening
• Risk Analysis
Regional Outlook (Revenue, USD Million, 2013 – 2024)
• North America
• Asia Pacific
• Latin America
• Middle East & Africa
• South Africa
number of years. Big companies are growing their geographic existence so as to increase general stake in the market.
The division of the Specialty Pulp and Paper Chemicals market on the source of Type of Application. The market can be divided into Printing, Packing, Labeling and others. The subdivision of packing ruled the business, during the past year and helped in growth of stake of the international capacity. Extensive uses of the product in the fields of Cups, Paper Tubes, Paper Plates, Take out Boxes, Corrugated Clamshell, and Packing of Foodstuff is an important supportive part in the progress of the market.
The division of the Specialty Pulp and Paper Chemicals market on the source of Type of Product. The statement shows the Manufacture, Profits, Price, Market stake and Development percentage of respective category. The market is divided into the types Process Chemicals, Functional Chemicals, Bleaching Chemicals, and Basic Chemicals.
The division of the Specialty Pulp and Paper Chemicals market on the source of Area. The statement divides market into a number of important Areas. The division is done with respect to Trades in terms of intake, Profits, Market stake and Development percentage in these areas, for the duration of the prediction. The area wise division of the market done like North America [U.S.A, Canada, Mexico], Europe [France, Spain, Germany, U.K., Italy, the Netherlands, Russia, Turkey], Asia Pacific [India, Japan, China, South Korea, Malaysia, Indonesia, Vietnam, Thailand, Australia, and New Zealand], Central & South America [Venezuela, Brazil, Argentina], Middle East & Africa [UAE, Saudi Arabia, Iran ]
By the source of geography, the area of Asia Pacific headed the market during the past year. It is estimated to hold its supremacy above the predictable future. Demand for the specialty paper for the application of packaging has an important capacity development in the area. Gush in retail marketing infrastructure, reinforced by increasing necessity for wrapped merchandises in the area of Asia Pacific, has motivated the market in the province.
Request a Free Sample Copy of Specialty Pulp and Paper Chemicals Market Report @ https://www.millioninsights.com/industry-reports/specialty-pulp-paper-chemicals-market/request-sample
The area of North America is expected to observe slow development because of strict rules relating to the manufacture of pulp and paper, enforced by ecological organizations for example the EPA. Yet, the business is expected to be motivated by growth in application variety of specialty papers and demand for biodegradable materials for reprocessed papers. The area’s biggest economy, the U.S.A, is expected to implement the usage of ecological and 100% biodegradable products. This will consequence in the development of the market.
The statement revises Trades in terms of intake of Specialty Pulp and Paper Chemicals in the market. Particularly in the areas of North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. It concentrates on the topmost companies operating in these areas and the nations. With reference to Trades, Price, Profits and Market stake for respective competitor in these areas. Some of the important companies, operating in the field on international level are Kemindo International, the Dow Chemical Company, Ashland Inc., SNF Floerger, Buck man Laboratories International, Inc.
Additional notable companies, operating in the field, on international level are Shell Chemicals, Evonik Industries AG, Kemira Oyj, BASF SE, and Akzo Nobel N.V.
Specialty Pulp & Paper Chemicals Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)
• Basic Chemicals
• Functional Chemicals
• Bleaching Chemicals
• Process Chemicals
Specialty Pulp & Paper Chemicals Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)
To read more reports of this category, Visit our blog: https://marketreporters.wixsite.com/chemicalsmarket
Specialty Pulp & Paper Chemicals Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)
• North America
• The Netherlands
• Asia Pacific
• South Korea
• New Zealand
• Central & South America
• Middle East & Africa
• Saudi Arabia